To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Abbvie US LLC
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute, on behalf of the Health Services Director, a purchase order with Abbvie US LLC in an amount not to exceed $825,000 and Letter of Commitment for the purchase of breast implants for Contra Costa Regional Medical Center (CCRMC), for the period from October 1, 2025 through September 30, 2028.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $825,000 over a three-year period and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Abbvie US LLC, through its subsidiary Allergan Aesthetics, markets the Natrelle line of breast implants. These implants are available in both silicone-filled and saline-filled options and are intended for breast augmentation as well as breast reconstruction. Certain textured implant models, specifically the BIOCELL line, were voluntarily recalled worldwide due to safety concerns. Abbvie also offers a warranty program, ConfidencePlus, on some implant models, which may cover replacement and other costs under defined conditions.
Breast implants are important for CCRMC to have on hand for surgical procedures because they are essential for breast reconstruction surgeries following mastectomy, injury, or congenital abnormalities. They allow surgeons to restore breast shape, symmetry, and volume, which can significantly improve a patient's physical appearance, psychological well-being, and quality of life. Having implants readily available ensures that reconstruction surgeries can be performed promptly without delays, supporting better patient outcomes and efficient surgical workflow. Additionally, the availability of different implant types and sizes allows surgeons to tailor procedures to each patient's specific needs....
Click here for full text